Publication | Closed Access

A Phase II Trial of Gemcitabine/Carboplatin with or Without Trastuzumab in the First-Line Treatment of Patients with Metastatic Breast Cancer

Metastatic Breast CancerBreast OncologyPhase Ii TrialMedicinePharmacologyBreast CancerPharmacotherapyFirst-line TreatmentCancer TreatmentOncology